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Anaphylaxis is a severe and life-threatening systemic hypersensitivity reaction.  Ketorolac is a popular drug used for 
patient-controlled analgesia.  Although anaphylactic reaction to ketorolac has not been frequently reported, it can 
develop by way of several mechanisms.  A 41-year-old male patient was scheduled for laparoscopic correction of a 
perforated gastric ulcer. Emergency surgery was performed under general anesthesia with no complications.  Near 
the end of anesthesia administration, ketorolac in a loading dose was administered intravenously in order to launch 
patient-controlled analgesia.  Following injection, urticaria-like skin lesions, including rashes and wheels appeared 
systemically; tachycardia and breathing difficulty with oxygen desaturation also developed.  Through additional 
inquiry into the patient’s drug history, past experience with ibuprofen allergy was identified.  Antihistamine, steroid, 
and aminophylline were administered, and continuous positive airway pressure by full facial mask was applied to 
relieve bronchospastic symptoms. The patient recovered without further complications.  (Korean J Anesthesiol 2010; 
58: 565-568)
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    Nowadays, most anesthesiologists not only administer 
anesthesia for surgery, but have also extended their role to 
the area of postoperative pain relief. After surgery, drugs and 
pain relief methods are used in a variety of ways; the most 
common drugs are narcotic analgesics and nonsteroidal 
antiinflammatory drug (NSAIDs), which are commonly mixed 
with a patient-controlled analgesia (PCA) device via intravenous 
line. Reduction of the side effects of narcotic analgesics while 
at the same time maintaining optimal conditions for the 
purpose of a pain relief drug as a secondary is an advantage of 
using PCA with NSAIDs [1,2]. Ketorolac is the most commonly 
used drug for intravenous injection, and ketorolac can cause 
anaphylaxis associated with anesthetic complications. NSAIDs-
induced anaphylaxis can be triggered by both the immune 
system and the non-immune system. Therefore, if the reaction 
is anaphylactoid via a non-immune mechanism, anaphylaxis 
can occur regardless of the structure of the NSAIDs. Therefore, 
patients who have shown hypersensitivity to NSAIDs require 566 www.ekja.org
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special care in with regard to use of NSAIDs [3].
    In this case, we report on a case of anaphylactoid reaction that 
developed after ketorolac injection in a loading dose for PCA, 
along with a review of the literature.
Case Report
    A 41-year-old patient visited the emergency center with a 
complaint of acute abdominal pain. The height of the patient 
was 175 cm, and his weight was 71 kg. He was diagnosed with 
acute gastric ulcer perforation, and underwent emergency 
surgery for laparoscopic repair. Other than drinking one 
bottle of distilled liquor daily, the patient’s past medical 
history revealed no unusual findings. Premedication was 
not administered. Meperidine and nalbupine were injected 
in an intravenous loading dose, followed by intravenous 
administration of Meperidine 200 mg mixed with a normal 
saline drip for the purpose of pain control during the patient’s 
entery into the operation room. After preoxygenation, the 
original anaesthetic consisted of thiopental and succinylcholine 
administered intravenously for induction. This was followed by 
administration of sevoflurane and vecuronium for maintenance 
of anaesthesia. Before administration of anaethesia, the 
patient’s vital signs included a blood pressure of 119/82 mmHg, 
regular sinus rhythm of pulse rate 91 beats/min, and peripheral 
oxygen saturation of 100%. Surgery was performed without 
unusual findings. For control of postoperative pain, fentanyl 
1,000 μg and ketorolac 180 mg in the saline solution were made 
by mixing 100 ml total, of which the loading dose of 10 ml and 
the remaining 90 ml prepared as a PCA device (Accufuser plus 
1008M, Wooyoung medical, Korea) and were mounted inside. 
Following surgery of 1 hour 40 minutes duration, the loading 
dose of 9 ml of 10 ml (fentanyl 90 μg, ketorolac 16.2 mg) for PCA 
was administered intravenously for control of postoperative 
pain. PCA was then connected to the intravenous line by 1 ml/
hr basal continuous infusion. Neuromuscular blocker was then 
reversed by pyridostigmine and glycopyrrolate. Extubation 
was performed without complications, and the patient was 
transported to the postanesthetic care unit (PACU). At that time, 
his vital signs included blood pressure of 122/83 mmHg, regular 
sinus rhythm of pulse rate 80 beats/min, and normal peripheral 
oxygen saturation. Skin examination showed no unusual 
finding. 
    After 30 minutes in PACU, erythematous rashes developed on 
the neck. Therefore, chlorpheniramine 4 mg and dexametha-
sone 5 mg were administrated intravenously. After 10 minutes, 
wheals with erythematous rashes developed on the neck 
and upper limbs. Therefore, chlorpheniramine 4 mg and 
hydrocortisone 100 mg were administrated intravenously. After 
5 minutes, angioedema of the face was newly observed, with 
no relief from any symptoms; both erythematous rashes and 
wheals spread over the entire body, including both extremities. 
At that time, body temperature indicated mild hyperthermia 
at 37.4
oC. His vital signs showed low normal borderline blood 
pressure; however, his pulse rate increased gradually, up to 
120 beats per minute. Oxygen saturation decreased 92% by 
peripheral oxygen saturation. Findings from arterial blood gas 
analysis were pH 7.38, PCO2 41.6  mmHg, PO2 55.9 mmHg, 
and oxygen saturation 89.1%. Findings from examination 
with auscultation included wheezing, stridor on both lung 
fields, and a decreased breathing sound on both lower lung 
fields. Further inquiry into the patient’s past medical history 
revealed hypersensitivity to ibuprofen, one of the NSAIDs. 
Therefore, anaphylaxis was suspected. Consequently, the PCA 
device was removed from the patient’s intravenous line. In 
addition, aminophyline 250 mg and hydrocortisone 200 mg 
mixed in 100 ml normal saline respectively were administrated 
intravenously during intravenous fluid challenge. A full face 
mask (Mirage Quattro, ResMed, Australia) was applied with 
FiO2 1.0 and continuous positive airway pressure (CPAP) for 
improvement of oxygen saturation. After 5 minutes, his oxygen 
saturation improved. After 15 minutes, his oxygen saturation 
was maintained at 100% by FiO2 0.6. Therefore, the full face 
mask was replaced with a re-breathing oxygen mask (Medium 
concentration oxygen mask, Telflex Medical, USA) as 5 L/
minute oxygen. His symptoms showed no further worsening. 
After an hour, his general condition showed significant im-
provement with reduced erythematous rashes and wheals; 
however, he was transferred to the surgical intensive care unit 
due to the need for continuous monitoring. The next day, 
he was transferred to the general ward, and was discharged 
without further complications.
Discussion
    The European academy of allergy and clinical immunology 
(EAACI) nomenclature committee proposed a broad definition 
of anaphylaxis as a severe, life-threatening, generalized 
or systemic hypersensitivity reaction [4]. Therefore minor, 
localized or non-systemic reactions, such as erythematous 
rashes or wheals are not included in the definition of 
anaphylaxis. Clinical features of anaphylaxis may be identical; 
however, anaphylaxis may be divided into allergic anaphylaxis 
and non-allergic anaphylaxis. Allergic anaphylaxis is further 
subdivided into an immunoglobulin E mediated reaction and 
an immunological mechanism (such as IgG, complement 
activation) mediated reaction, with the exception of IgE [3]. A 
general example of an IgE mediated allergic anaphylaxis is an 
allergic reaction to peanut ingestion, and blood transfusion 
reactions are an example of an non-IgE mediated allergic 567 www.ekja.org
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anaphylaxis [5]. Exact etiology for non-allergic anaphylaxis is 
unknown; however, potential pathogenic mechanisms include 
idiosyncratic events, non-specific complementary activation, 
activation of humoral proteolytic systems, such as the clotting 
cascade, and direct histamine release [6]. Therefore, allergic 
anaphylaxis can be elucidated by skin test or drug-specific 
testing for IgE; however, non-allergic anaphylaxis cannot be 
explained by testing for specific sensitivity. The more important 
point is that the one is often more severe with subsequent 
administration of the causal drug, but the other tends to be 
similar with repeat administration of the causal drug. The other 
is more likely dose-dependent [5]. Clinical signs and symptoms 
can occur within seconds, but usually start within 5-10 minutes 
after intravenous administration of the responsible agent. 
Anaphylaxis usually resolves in 2-8 hours [3,7].
    Prevalence of anaphylaxis during anesthesia administration 
has never been reported in Korea. Estimated overall frequency 
between 1 in 3,500 and 1 in 25,000 has been reported in studies 
from France and Australia [5]. Mortality from these reactions 
ranges from 3% to 6%, and an additional 2% of patients 
experience significant residual brain damage [7].
    The exact diagnosis of anaphylaxis during anesthesia is diffi-
cult to ascertain. Because a number of drugs are administered 
simultaneously under anesthesia, these drugs can be implicated 
in allergic reactions, even if there is disparity between these 
drugs [7]. Major causal agents of anesthesia-related anaphylaxis 
include muscle relaxants (60%), latex (20%), antibiotics (15%), 
and colloids (4%), in that order. Outside of that, anesthesia-
related anaphylaxis rarely occurs with NSAIDs, opioids, and 
local anesthetics [3,8].
    Even if NSAIDs rarely cause anesthesia-related anaphylaxis, 
NSAIDs induced anesthesia-related anaphylaxis has been 
reported in Korea [9]. Mechanisms of NSAIDs induced anaphy-
laxis include inhibition of cyclo-oxygenase (COX)-1 iso-enzyme 
with subsequent depletion of prostaglandin E2, unstrained 
synthesis of cysteinyl leukotrienes (cys-LT), and release of 
mediators from mast cells and eosinophils [10]. Therefore, 
anaphylaxis rarely occurs with weak COX-1 inhibitors, such as 
paracetamol and partial inhibitors of both COX-1 and COX-
2, such as nimesulide and meloxicam, and selective COX-
2 inhibitors at usual drug doses; it generally occurs only at 
high drug doses [11]. Currently, diagnosis of ASA and NSAID-
induced hypersensitivity reactions can only be established 
with provocative drug testing [10]. As previously mentioned, 
because of non-IgE mediated mechanisms, there are currently 
no available sIgE assays for ASA or NSAID. The experimental 
diagnostic value of histamine and cys-LT release assays and 
flow-assisted quantification of in vitro activated basophils 
remains to be established [7]. 
    In this case, when the patient received preoperative intra-
venous administration of meperidine for control of pain, he 
did not develop symptoms or signs associated with meperi-
dine. Therefore, opioids can be excluded as a cause of ana-
phy  laxis. Also, drugs administered between the period 
following surgery and PACU before anaphylaxis were drugs 
for PCA and pyridostigmine and glycopyrrolate for reversal 
of neuromuscular blocker. Through further inquiry into his 
past medical history, hypersensitivity to ibupropen and a 
hypersensitivity reaction were found to have occurred after 
injection of an intravenous loading dose for PCA. Hence, 
comprehensively, ketorolac was more suspicious than fentanyl 
as the PCA’s that caused anaphylaxis. Also, anaphylaxis 
occurred 30 minutes after injection of ketorolac, and the 
patient had experienced hypersensitivity reactions to other 
NSAIDs. Therefore, in this case, anaphylaxis can be presumed 
anaphylactoid reaction as non-allergic anaphylaxis less than 
IgE-mediated allergic anaphylaxis reaction definitely.
    When anaphylaxis is diagnosed, rapid management is critical. 
Immediate treatment of allergic anaphylaxis and non-allergic 
anaphylaxis are identical. The major immediate treatments 
consist of epinephrine, oxygen 100%, intravenous fluid 
challenge, and intubation for airway maintenance [3,12,13]. 
Epinephrine should be administered as early as possible. An 
initial dose of 50 μg (0.5 ml, 1 : 10,000 solution) intravenously 
or 300-500 μg (0.3-0.5 ml, 1 : 1000 solution) intramuscularly 
is recommended [6]. Epinephrine has alpha-agonist activity, 
which reverses vasodilation. In addition to having a beta-
agonist, which is inotropic, and also a bronchodilator, it 
reduces further release of mediators, such as histamine and 
leukotrienes [14]. Epinephrine is metabolized in liver and its 
half-life is 15 minutes. Therefore, epinephrine should be given 
repeatedly or infused continuously if necessary. Intravenous 
injection of chlorpheniramine 10 mg as an anti-histamine 
agent and hydrocortisone 200 mg (0.25-1.0 g) as a steroid are 
recommended. In case of severe bronchospasm, aminophylline, 
salbutamol, and magnesium sulphate can be given, and a beta-
2 agonist may be inhaled using a metered-dose inhaler [3,6]. 
Hypotension leads to systemic vasodilation. Therefore, 0.9% 
normal saline or lactated Ringer’s solution are given rapidly, 
and the patient should be placed in the supine position. 
Hypotensive patients must avoid a sitting or elevated upper 
body position. Symptoms of dizziness and loss of consciousness 
can be induced by hypotension. At that time, the patient should 
be placed in the supine position, and venous return can be 
increased by elevation of both legs if necessary [3,15].
    In this case, the patient showed a mild hypersensitivity 
reaction. Therefore, only anti-histamine and steroid were 
administered intravenously. When the hypersensitivity reaction 
became systemic, tachycardia and de-saturation developed. 
However, hypotension requiring adrenaline did not occur. To 568 www.ekja.org
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relieve bronchospasms, administration of aminophylline and 
establishment of CPAP with full face mask were attempted. 
At that time, the patient was mentally alert and had no severe 
bronchospasm. Hence, improvement of arterial oxygenation 
by use of a non-invasive full face mask, without intubation 
was attempted. Application of a full face mask was effective for 
improvement of arterial oxygenation, even though he had a 
naso-gastric Levin tube.
    Even if anesthesia-related anaphylaxis is uncommon, ana-
phylaxis is fatal. A number of drugs are administrated simul-
taneously during the peri-operative period, and the patient 
can come in contact with causal agents directly through the 
site of the operation. Therefore, in the event of anesthesia-
related anaphylaxis, identification of the causes of anaphylaxis 
is difficult. Hence, standardized methods for selection of 
high risk patients must be established through reported 
cases of anaphylaxis and close examination of the patient. In 
addition, we must be fully aware of differential diagnosis and 
appropriate treatment for anaphylaxis. In so doing, diagnosis 
and management of anaphylaxis must be rapid and exact.
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